Before using naltrexone, tell your healthcare provider about your medical history, especially if you have: kidney disease liver disease (as it may cause liver dysfunction or hepatitis) depression/suicidality current or recent (7-14 days) use of any type of opioid or opiate drugs This drug may make you dizzy or drowsy or impair your judgment

Plaintiffs in the litigation report experiencing these specific digestive system complications: Gastroparesis (stomach paralysis): The most common injury alleged in lawsuits, this condition involves partial or complete paralysis of stomach muscles that prevents proper digestion and can persist even after discontinuing medication Ileus (intestinal blockage): Added to FDA warning labels in September 2023 after post-marketing reports, this condition stops intestinal movement and can lead to life-threatening complications including infection and tissue death Intestinal obstruction and pseudo-obstruction: Physical or functional blockages requiring emergency hospitalization and often surgical intervention to prevent bowel perforation Chronic severe symptoms: Persistent vomiting, uncontrollable nausea, dangerous dehydration requiring IV fluids, and electrolyte imbalances necessitating repeated emergency department visits The FDAs decision to update warning labels demonstrates growing concern about these complications

CST Affordable appointments and medication Oral and injectable options available No subscription or membership required Cons Doesnt accept insurance Doesnt handle prior authorizations for GLP-1 medications Most follow-ups conducted via chat Price $49 per appointment, medication starting at $149 per month Key Specs Accepts insurance: No Weight loss program included: No GLP-1 brand names offered: Wegovy, Zepbound Type of GLP-1 available: Oral and injectable Cancel any time: Yes, no subscription or membership required Now you can get prescribed GLP-1 medications online through Walgreens Weight Management
Importantly, GIP receptor sensitivity is impaired in prolonged hyperglycemic states due to receptor downregulation but can be restored upon achieving euglycemia through complementary GLP-1 action [38,39]